Biocon LimitedNSE: BIOCON

Press Release Dec 14 2022

· Issued by Biocon Limited

Filed with NSE ·

Dear Sir/Madam,Please find enclosed the press release titled ���Biocon Limited initiates clinical study of Itolizumab for Ulcerative Colitis in India���.The above information will also be available on the website of the Company at www.biocon.com.Kindly take the same on record and acknowledge.

View Attachment

6ix hasn’t read this filing yet.

Biocon Limited on 6ix

Earlier from Biocon

Later from Biocon

All Biocon news releases